Twitter Facebook Google Plus YouTube LinkedIn Instagram
Show telephone contact numbers
Hide telephone contact numbers
General enquiries:
Book an appointment:
Self-pay enquiry:
05 June 2019
Cancer care
Hospital announcements
Patient services

The London Clinic is one of a small number of hospitals in the UK to offer adult patients with diffuse large B-cell lymphoma – an aggressive form of blood cancer - a new, cutting-edge form of immunotherapy called CAR-T cell therapy

Blood cancer representative image

The CAR-T (chimeric antigen receptor T-cell) cell therapy works through the collection of immune cells (T cells) from the blood of patients. These T-cells are then genetically modified to destroy cancer cells in a laboratory and given back to the patient. This therapy is for patients who have no other treatment options having failed conventional chemotherapy.

A phase 2 clinical trial of 111 patients, has shown positive outcomes with 52% of patients treated with CAR-T therapy, living for 18 months after treatment. Real-world data is at an early stage but consistent with this positive outcome. 

CAR-T therapy is approved by the UK’s National Institute for Health and Care Excellence (NICE). The London Clinic is HTA licensed and JACIE accredited and with access to a level 3 intensive care unit, patients who suffer any side-effects from the treatment can be cared for at one central hospital site.

Professor John Gribben, who is leading the treatment at The London Clinic, says: "CAR-T cell therapy is an exciting advancement in the treatment of blood cancers, offering a new, final treatment option for patients when others haven’t had the result they need from conventional therapy. 

“Diffuse large B-cell lymphoma is an aggressive form of blood cancer. So far, this treatment is showing promising outcomes for many patients, letting them return to normal lives with their families and loved-ones. The London Clinic is a pioneering hospital and we are proud to be in a position to offer this treatment to our patients in the UK, Europe and from international countries,” adds Professor Gribben.

Mr Satya Bhattacharya, Medical Director of The London Clinic, says: "The London Clinic is committed to bringing together its strengths in clinical service, research, and innovation to successfully deliver new treatments such as CAR-T cell therapy and create positive outcomes for our patients.

“Our team of internationally-renowned haematologists and clinical nurses have specialist experience and expertise in all aspects of treating blood cancers and we are excited to be one of a small number of hospitals offering this exciting new treatment. Our charitable ethos means that we are committed to advancing healthcare knowledge across the wider community.” 

Further information

To refer a patient, please telephone 020 7535 5503 or email

London Haematology

The consultants who make up London Haematology have special interests in all aspects of haematology, including:

  • leukaemias
  • myeloma
  • anaemia
  • coagulation
  • thrombotic disorders.

The work is done at our specialist centre for adult bone marrow transplantation and stem cell harvesting.

London Haematology

Share to Twitter Share to Facebook Share to LinkedIn Share to Google Plus

Main numbers

Concierge service: +44 (0) 203 219 3323 International office: +44 (0) 203 219 3266 Invoice and payment enquiries: +44 (0) 207 616 7708 

Your call may be recorded for training and monitoring purposes.

Medical service numbers

Breast services appointments: +44 (0) 207 616 7653 Diagnostics appointments: +44 (0) 207 616 7653 Endoscopy appointments: +44 (0) 207 616 7760 Eye centre appointments: +44 (0) 207 616 7768 Haematology appointments: +44 (0) 207 535 5503 Kidney services appointments: +44 (0) 207 224 5234 Liver services appointments: +44 (0) 207 616 7719 Physiotherapy appointments: +44 (0) 207 616 7651 Radiology appointments: +44 (0) 207 616 7653

Close menu